Live Webinar

Delivering Cellular Therapy in Community Oncology: OHC’s Approach

Presented by The Community Oncology Alliance

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image

Authors

Wrenda Teeple, PharmD
Latest Article

Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans

This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.

Trish Stievater, PharmD
Latest Article

Navigating Compounded Semaglutide: What Health Care Providers Need to Know

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.

Karoline Mortensen, PhD
Latest Article

The Societal Costs of Food Insecurity: Implications for Managed Care Strategies

Food insecurity among working-age US adults has significant economic consequences, primarily driven by increased job instability and income insecurity.

Geoffrey T. Manley, MD, PhD
Latest Article

Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury

Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.

Neil J. MacKinnon, PhD
Latest Article

Optimizing Revisit Intervals: Reducing Variability to Enhance Health Care Efficiency

The authors explore the limitations of the current system of revisit interval assignment and discuss the importance of standardization to optimize patient health care outcomes.

Lauren Oshman, MD, MPH, DABOM
Latest Article

Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management

The high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.

Amanda C. Chen, MS
Latest Article

Medical Loss Ratio’s Role in the Large Group Insurer Market

The authors used medical loss ratio forms to assess trends in premiums, medical claims, administrative costs, quality improvement, and margins in the large group insurer market.

David Kindig, MD, PhD
Latest Article

Integrating Research, Health Care, and Community at Scale to Address the Population Health Question

The authors discuss the need to repair a house divided among research, health care, and the multisector health community.

M. Ella Lewie, MSW, LSW
Latest Article

Potential Health Literacy Resources for Health Plans: A Narrative Review

Several evidence-based health literacy resources may be beneficial in health plan settings to improve organizational health literacy, personal health literacy, and health equity.

Jingqiu Zhu, FSA, MAAA
Latest Article

Out-of-Pocket Costs for Diabetes Medications in Employer-Sponsored Health Plans

This study found high out-of-pocket costs for branded diabetes medications in employer-sponsored health plans.

Clipper F. Young, PharmD, MPH
Latest Article

Harnessing AI for Population Health: A Call to Action for Policy Makers and Health Care Leaders

The authors detail how artificial intelligence could be used in primary, secondary, and tertiary prevention to improve health outcomes and provide better value-based care.

Patricia Adam, MD, MSPH
Latest Article

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

This analysis of more than 250,000 adults at least 50 years old with chronic conditions showed lower portal use among older, non–English-speaking, and Black patients, underscoring digital health equity gaps.

Joshua K. Johnson, DPT, PhD
Latest Article

High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care Organization

High-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.

Doug Landsittel, PhD
Latest Article

Integrated Care for Chronic Conditions: A Randomized Care Management Trial

The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic conditions.

James O. Mudd, MD
Latest Article

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

The analysis highlighted a shift in heart failure diagnoses, with hypertensive heart disease with and without chronic kidney disease as prevalent diagnoses, underlining coding variability and implications for research.

Devika A. Shenoy, BS
Latest Article

Interventions Addressing Cost-Related Medication Nonadherence in Diabetes: A Scoping Review

Many US patients with diabetes cannot afford their medical care. The authors review the impact of interventions that reduced and/or eliminated diabetes-related costs.

Michael D. Dang, MS
Latest Article

Utilization of Social Determinants Z Codes and Health System Characteristics, 2015-2024

We identify the health system characteristics associated with greater or lesser documentation of patients’ social determinants of health.

Brady P. Horn, PhD
Latest Article

An Assessment of Nurse Practitioner Low-Value Care Use in Primary Care

Primary care nurse practitioners were found to use low-value care at lower or relatively similar rates compared with the general clinician population.

Lauren Madigan, MD

Lauren Madigan, MD, associate professor of dermatology, University of Utah.

Latest Article

Top Reasons Dermatologists Value the AAD 2026 Annual Meeting

Key session speakers and abstract presenters share their highlights of attending AAD 2026.

Marie Bosslett
Latest Article

Intralesional Cemiplimab Shows Promise as a Nonsurgical Alternative for Early-Stage CSCC

A Winter Clinical Miami poster highlights intralesional cemiplimab for early CSCC, showing rapid responses and positive safety vs surgery.

Elena Koundourakis, PhD

Elena Kounourakis, PhD, head of orexin franchise development & neuroscience programs, Takeda.

Latest Article

Oveporexton Shows Gains in Cognition, Sleep Quality in Narcolepsy: Elena Koundourakis, PhD

Elena Koundourakis, PhD, discusses phase 3 trial improvements in cognition, REM normalization, and nighttime sleep quality in patients with narcolepsy.

Pooja Gokhale, PharmD
Latest Article

Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine.

Lianne Granata, PharmD
Latest Article

Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Jay S. Pickern, DBA
Latest Article

Prior Authorizations and the Adverse Impact on Continuity of Care

Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.

Kate Goodrich, MD
Latest Article

First-Time Medicare Advantage Enrollees Demonstrate Increasing Demographic and Clinical Diversity

As Medicare Advantage grows, first-time enrollees demonstrate increasing demographic and clinical diversity, indicating that benefits should be designed to reflect the population’s changing composition.

Aleata Postell

Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy.

Latest Article

CenterWell Pharmacy Expands Access to Obesity Medications Through Employer Program: Aleata Postell

Aleata Postell discusses CenterWell Pharmacy's partnership with Eli Lilly to dispense FDA-approved obesity management drugs.

Mona Kilany, PhD
Mona Kilany, PhD
Latest Article

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

Eye care access for underserved patients with diabetes is limited and poorly understood. We identified barriers and innovative solutions to improve overall care and establish evidence-based practices.

Grace Elsey, PharmD, BCOP
Latest Article

Inflation Reduction Act Impact on the Hematology/Oncology Treatment Landscape

The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and potentially reshape prescribing patterns in oncology and hematology.

Jennifer L. Dotson, MD, MPH
Latest Article

The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance

Infliximab biosimilars created price competition causing insurance claims costs for infliximab originator and infliximab biosimilars to decrease, generating significant savings to the health care system.

Monisa Aijaz, MD, PhD
Monisa Aijaz, MD, PhD
Latest Article

Should I Stay, or Should I Go? Provider Considerations for Leaving Medicaid Managed Care Organizations

This qualitative study examines the factors that provider organizations consider when contracting with managed care organizations under North Carolina’s Section 1115 demonstration waiver.